Description
This oral capsule presents SLU-PP-332, a small-molecule agonist of the estrogen-related receptors (ERRs) linked to oxidative metabolism, in a solid-dose research format.
Laboratory studies in cell and animal models have explored mitochondrial production, fat oxidation, and exercise-mimetic metabolic shifts. The oral capsule format supports route-of-delivery research into metabolic gene regulation.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.